Cite Filings / DYN / 0001972481-24-000071
Feed Companies Filings Check
Sign in
144

Sale of Securities

Dyne Therapeutics, Inc. · Filed 2024-03-12 · Acc 0001972481-24-000071

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-04-04 144 Sale of Securities
  • 2024-03-12 144 Sale of Securities
  • 2024-03-12 4 Chief Medical Officer sold 2,615 shares at an average $25.65 ($67,082)
  • 2024-03-12 4 SVP, Head of Finance & Admin. sold 88,924 shares at an average $26.19 ($2,329,007)
  • 2024-03-12 4 CEO & President sold 429,730 shares at an average $25.89 ($11,125,776)
  • 2024-03-12 4 Chief Scientific Officer sold 2,081 shares at $25.70 ($53,482)
  • 2024-03-11 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…